增强CT对比剂多剂量与单剂量包装的成本最小化分析:来自中国真实世界数据的结果
该观察性研究于2018年10—11月在中国8省8家医院开展,纳入1032例患者(100 mL包装776次CT检查,200 mL包装382次CT检查),平均注射对比剂75.46 mL。线性回归显示扫描部位数、对比剂规格(0为100 mL,1为200 mL)、是否为CTA及患者体重均对注射量有正向影响(均p<0.001)。与单剂量包装相比,多剂量包装结合不同报销单元可显著减少浪费,从支付方角度每例增强CT估计节省5.59—6.04美元,从患者角度每例节省12.84—14.66美元,合计每例减少18.29—20.70美元。
要点
- 多剂量包装结合报销单元较单剂量包装可降低增强CT对比剂成本,合计每例节省18.29—20.70美元。
- 扫描部位数、对比剂规格、是否为CTA及患者体重均与注射量正相关(均p<0.001)。
- 平均注射量为75.46 mL,提示单剂量100 mL包装存在剩余浪费空间。
诊断标准与关键数值
- 平均注射对比剂体积为75.46 mL。
- 扫描部位数、对比剂规格(0为100 mL,1为200 mL)、是否为CTA(0为非CTA,1为CTA)及患者体重均对注射量有正向影响(均p<0.001)。
- 从支付方角度,每例增强CT估计节省5.59—6.04美元;从患者角度每例节省12.84—14.66美元;合计每例减少18.29—20.70美元。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE. Utilization and waste in diagnostic imaging have substantially increased worldwide. The purpose of this study was to highlight the utilization of contrast material and cost savings resulting from implementation of a multidose bulk IV contrast delivery system. MATERIALS AND METHODS. An observational study was conducted in October-November 2018 in eight hospitals in eight provinces in China. Contrast media specifications were 100-mL single-use IV contrast vials and 200-mL and 500-mL bulk packaging. Linear regression analysis was performed to identify the factors influencing contrast media use. Cost-minimization and sensitivity analyses were performed from patient and payer perspectives. RESULTS. A total of 1032 patients, some of whom underwent more than one CT examination, were enrolled in this study (100-mL package, 776 CT examinations; 200-mL package, 382 CT examinations). The mean injected volume of contrast medium was 75.46 mL. Number of scanned body parts, specification of amount of contrast medium (0, 100 mL; 1, 200 mL), whether the examination was CT angiography (CTA) (0, not CTA; 1, CTA), and patient weight all had a positive impact on the injected volume of contrast medium (p < 0.001 for all variables). Implementation of a multidose bulk IV contrast delivery system combined with different reimbursement units resulted in substantial waste reduction, estimated at US$5.59-6.04 per contrast-enhanced CT examination from the payer perspective, US$12.84-14.66 per examination from the patient perspective, and a total reduction of US$18.29-20.70 per examination. CONCLUSION. Use of multidose packaging of contrast media combined with reimbursement units for patients undergoing IV contrast-enhanced CT was found to be cost saving compared with use of single-dose packaging.
引用
- Wei Y, He Z, Zhang C, et al. Cost-Minimization Analysis of Multidose and Single-Dose Packaging of Contrast Media for Contrast-Enhanced CT: Results From Real-World Data in China. AJR Am J Roentgenol. 2020. PMID: 32208008. doi:10.2214/AJR.19.22006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。